- Home
- RELI vs RDHL Comparison
RELI vs RDHL Comparison
Compare RELI & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELI
- RDHL
- Stock Information
- Founded
- RELI 2013
- RDHL 2009
- Country
- RELI United States
- RDHL Israel
- Employees
- RELI N/A
- RDHL N/A
- Industry
- RELI Specialty Insurers
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- RELI Finance
- RDHL Health Care
- Exchange
- RELI Nasdaq
- RDHL Nasdaq
- Market Cap
- RELI 4.7M
- RDHL 3.9M
- IPO Year
- RELI N/A
- RDHL N/A
- Fundamental
- Price
- RELI $0.72
- RDHL $1.04
- Analyst Decision
- RELI
- RDHL
- Analyst Count
- RELI 0
- RDHL 0
- Target Price
- RELI N/A
- RDHL N/A
- AVG Volume (30 Days)
- RELI 3.2M
- RDHL 1.5M
- Earning Date
- RELI 11-06-2025
- RDHL 09-05-2025
- Dividend Yield
- RELI 4.65%
- RDHL N/A
- EPS Growth
- RELI N/A
- RDHL N/A
- EPS
- RELI N/A
- RDHL N/A
- Revenue
- RELI $13,115,995.00
- RDHL $9,550,000.00
- Revenue This Year
- RELI N/A
- RDHL $381.91
- Revenue Next Year
- RELI N/A
- RDHL N/A
- P/E Ratio
- RELI N/A
- RDHL N/A
- Revenue Growth
- RELI N/A
- RDHL 157.62
- 52 Week Low
- RELI $0.61
- RDHL $1.01
- 52 Week High
- RELI $5.11
- RDHL $8.75
- Technical
- Relative Strength Index (RSI)
- RELI 42.08
- RDHL 33.58
- Support Level
- RELI $0.61
- RDHL $1.01
- Resistance Level
- RELI $0.76
- RDHL $1.07
- Average True Range (ATR)
- RELI 0.06
- RDHL 0.09
- MACD
- RELI -0.01
- RDHL 0.01
- Stochastic Oscillator
- RELI 33.84
- RDHL 7.58
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.